Is imedpharm.lv Safe? Security Analysis for Imedpharm SIA
http://imedpharm.lv/index.php/ruCheck if imedpharm.lv is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for imedpharm.lv
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Imedpharm SIA is a licensed wholesale pharmaceutical company based in Latvia, specializing in the international wholesale distribution of medicaments and medicinal goods. The company serves markets in Europe, CIS countries, Caucasus, and Central Asia, offering products from leading global pharmaceutical manufacturers. The team has over 15 years of experience and adheres to Good Distribution Practice (GDP) and Good Storage Practice (GSP) standards, indicating a commitment to quality and regulatory compliance. The website presents professional content focused on business-to-business pharmaceutical wholesale services, targeting international medical suppliers and wholesalers. Technically, the website is built with basic HTML5, CSS, and minimal JavaScript, without any detected CMS or advanced frameworks. The site is accessible and well-structured but lacks modern security headers, privacy policies, and cookie consent mechanisms. Mobile optimization and accessibility are basic, and no analytics or tracking technologies are present, indicating a minimal digital footprint. The absence of WHOIS data due to query limits limits full domain trust verification. From a security perspective, the website uses HTTPS (assumed from base href https://), but no advanced security headers or incident response contacts are published. No forms or user input fields are present, reducing attack surface but also limiting user interaction. The lack of privacy and cookie policies suggests incomplete GDPR compliance. Overall, the security posture is moderate but could be improved with better headers, policies, and transparency. The overall risk assessment is moderate with no critical vulnerabilities detected. Strategic recommendations include implementing comprehensive privacy and cookie policies, enhancing security headers, publishing vulnerability disclosure or security.txt files, improving mobile and accessibility features, and obtaining WHOIS transparency to boost trust. These steps will strengthen compliance, security posture, and user trust in the digital presence of Imedpharm SIA.
Detected Technologies
14 urgent findings need attention
1 critical · 13 high
- + 6 more findings in the full report below
Keep imedpharm.lv under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
7 findings
20/100
GDPR Compliance
4 findings
25/100
NIS2 Compliance
8 findings
17/100
Email Security
4 findings
75/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Imedpharm SIA operates as a small-sized, licensed pharmaceutical wholesaler with a focus on international markets including Europe, CIS, Caucasus, and Central Asia. Their business model is B2B wholesale distribution of medicaments and medicinal goods sourced from leading global manufacturers. The company leverages a team with over 15 years of experience, positioning itself as a reliable regional player with compliance to GDP and GSP standards. The website content and contact details support a professional and credible business presence. However, the lack of published privacy, cookie, and terms policies, as well as absence of social media or analytics integrations, suggests a conservative digital marketing approach. The partnership with a design agency (dizainodin.ru) indicates external support for branding. The company appears focused on maintaining regulatory compliance and operational quality rather than aggressive online marketing or expansion. No subsidiaries or parent companies are indicated.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The current security posture of the website is moderate. The site is accessible over HTTPS, which is mandatory for secure communications, but no explicit security headers such as Content-Security-Policy, X-Frame-Options, or X-Content-Type-Options are detected, which are recommended to mitigate common web vulnerabilities. There are no forms or user input fields, reducing exposure to injection attacks, but also limiting user engagement. The absence of privacy and cookie policies indicates gaps in GDPR compliance and user data protection transparency. No incident response or security contact information is published, which could delay response to security incidents. The lack of vulnerability disclosure or security.txt files further reduces transparency. No analytics or tracking scripts are present, minimizing privacy risks but also limiting user behavior insights. Overall, the website demonstrates basic security hygiene but requires enhancements to meet modern compliance and security best practices.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and publish a comprehensive privacy policy and cookie policy with GDPR compliance details.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Imedpharm SIA
Imedpharm SIA is a licenced wholesale pharmaceutical company specializing in international wholesale of medicaments and medicinal goods. They cooperate with European, CIS, Caucasus, and Central Asian countries and offer products from leading world pharmaceutical manufacturers. The team has over 15 years of experience and follows Good Distribution Practice (GDP) and Good Storage Practice (GSP).
good
consistent
Technical Stack
moderate
basic
basic
basic
Security Assessment
- No forms detected to analyze for secure input
- No exposed sensitive data found
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is accessible with full content and no blocking detected
Get this report delivered to your inbox
Receive a summary of the imedpharm.lv security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
EU business without adequate privacy measures
CRITICALEU businesses are subject to strict GDPR requirements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete imedpharm.lv security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
Weak DKIM Key
HIGHDKIM selector 'default' uses 1008-bit key
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 42 days
Mixed Content Detected
MEDIUM2 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
High-Risk Service Exposed: FTP
HIGHPort 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer
How does imedpharm.lv compare?
imedpharm.lv scores below average. Browse similar domains to see how competitors handle security.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the imedpharm.lv report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Want OffSeq to fix this?
Book a 30-minute remediation call
Our security engineers can resolve the high-severity findings identified in this report — from SSL misconfigurations and missing headers to compliance gaps and infrastructure hardening.
OffSeq provides end-to-end cybersecurity services: penetration testing, vulnerability remediation, compliance consulting, and continuous monitoring. View all services
Scan your own website
Liked the imedpharm.lv report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about imedpharm.lv
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published